Evidence map›Paper›PMID 34519641›Full record

ArticleeLife2021

Activation of mTORC1 and c-Jun by Prohibitin1 loss in Schwann cells may link mitochondrial dysfunction to demyelination.

Gustavo Della-Flora Nunes, Emma R Wilson, Edward Hurley, Bin He, Bert W O'Malley, Yannick Poitelon, Lawrence Wrabetz, M Laura Feltri

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Melatonin signalling in Schwann cells during neuroregeneration.Frontiers in cell and developmental biology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Gustavo Della-Flora NunesHunter James Kelly Research Institute, University at Buffalo, Buffalo, United States.ORCID 0000-0001-9323-3556
Emma R WilsonHunter James Kelly Research Institute, University at Buffalo, Buffalo, United States.ORCID 0000-0002-8069-0173
Edward HurleyHunter James Kelly Research Institute, University at Buffalo, Buffalo, United States.ORCID 0000-0002-1967-8933
Bin HeImmunobiology & Transplant Science Center and Department of Surgery, Houston Methodist Hospital, Houston, United States.
Bert W O'MalleyDepartment of Medicine and Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States.
Yannick PoitelonDepartment of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, United States.ORCID 0000-0001-9868-1569
Lawrence WrabetzHunter James Kelly Research Institute, University at Buffalo, Buffalo, United States.
M Laura FeltriHunter James Kelly Research Institute, University at Buffalo, Buffalo, United States.ORCID 0000-0002-2276-9182
Jacobs (United Kingdom) · GBUniversity at Buffalo, State University of New York · USAlbany Medical Center Hospital · USBaylor College of Medicine · USMethodist Hospital · US

Funding

SEX HORMONE RECEPTOR COMPONENTS AND THE CELL GENOMER01HD007857 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI DAVID M LONARD, JOHN P LYDON · 1985 to 2026
$14.6M
Transduction of Mechanical Stimuli in Myelination and Peripheral Nerve RepairR01NS110627 · NINDS · ALBANY MEDICAL COLLEGE · PI POITELON, YANNICK · 2020 to 2024
$2.1M
The Germ Cell Gene TDRD1 As A Novel Prostate Cancer BiomarkerR01CA211861 · NCI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI HE, BIN · 2017 to 2021
$1.8M
The prohibitin family and their function in myelination and axonal healthR01NS100464 · NINDS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI FELTRI, M. LAURA · 2016 to 2020
$1.7M
NCI NIH HHS R01 CA211861NICHD NIH HHS R01 HD007857NINDS NIH HHS R01 NS100464NINDS NIH HHS R01 NS110627
6 · The paper itself

Abstract

Schwann cell (SC) mitochondria are quickly emerging as an important regulator of myelin maintenance in the peripheral nervous system (PNS). However, the mechanisms underlying demyelination in the context of mitochondrial dysfunction in the PNS are incompletely understood. We recently showed that conditional ablation of the mitochondrial protein Prohibitin 1 (PHB1) in SCs causes a severe and fast progressing demyelinating peripheral neuropathy in mice, but the mechanism that causes failure of myelin maintenance remained unknown. Here, we report that mTORC1 and c-Jun are continuously activated in the absence of

Indexed as

AnimalsDemyelinating DiseasesMechanistic Target of Rapamycin Complex 1MiceMice, KnockoutMitochondriaMyelin SheathProhibitinsProto-Oncogene Proteins c-junRepressor ProteinsSchwann CellsUp-RegulationMechanistic Target of Rapamycin Complex 1ProhibitinsProto-Oncogene Proteins c-junRepressor Proteinsdemyelinationmechanistic target of rapamycinmitochondrial stress responsemousemyelin maintenanceneurosciencePHB1schwann cells

Identifiers

PMID34519641
PMCPMC8478418
OpenAlexW3200425247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.